guidanc goe higher ep
put beat led knees/mako neurotech trauma/
along broad strength medsurg organ growth margin
expand correct account chang guidanc
up growth om expans minimum
emphasi minimum ep
beat confid margin guidanc
anoth beat growth stay hot organ growth adjust
account chang one-less day compar last
growth support strong print ahead street
divis medsurg print vs street ortho print
vs street neuro/spin print vs street strength
neuro off-set weak spine cc market
describ still challeng core spine price doubl digit knee growth
particular notabl us well ahead market mako distract
competitor creat perfect storm guidanc up
organ growth fx
mako keep deliv mako instal global season
strong includ us last half
instal base upgrad total knee compani note
placement competit account last pace surgeon train
remain surgeon train total knee mako knee
done last use rough estim knees/q us
mako reach penetr mako continu prove naysay us includ
op margin expans well track report ep
upper end guidanc rang op margin year guidanc
minimum om expans emphasi minimum ep
guidanc rais compani expect
currenc fx expect beat confid around
margin seem conserv
pt ep upper-end med-tech reflect compani
better growth risk includ price volum growth competit
ep exclud amort begin
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
page
pleas see import disclosur inform page report
stryker corporationincom statementfy dec million except earn per growth organ growth good oper expens incom ex tax incom incl min incom ep share
page
pleas see import disclosur inform page report
stryker corporationrevenu modelfy dec neurotechnolog medic worldwidetot worldwidetot growth ww growth ex-fx growth
player world-wide orthoped market sale split reconstruct implant medic surgeri
raj denhoy certifi view express research report accur reflect person view subject secur
subject compani also certifi part compens directli indirectli relat specif recommend
view express research report
anthoni petron cfa certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat specif
recommend view express research report
catherin poulin-filion certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat specif
recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss report receiv
compens base part overal perform firm includ invest bank incom seek updat research
appropri variou regul may prevent us asid certain industri report publish period basi larg major
report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within period
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate secur averag
secur price consist expect total return price appreci plu yield plu minu within period
under-perform rate secur averag secur price consist expect total return price appreci plu yield minu
less within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/
jefferi polici
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic secur
regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project opinion
invest merit compani provid
jefferi methodolog assign rate may includ follow market capit matur growth/valu volatil expect total
return next month price target base sever methodolog may includ restrict analys market
p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
jefferi franchis pick includ stock select among best stock idea equiti analyst month period stock select
base fundament analysi may take account factor analyst convict differenti analysi favor risk/reward
ratio invest theme jefferi analyst recommend jefferi franchis pick includ buy rate stock number
vari depend analyst recommend inclus stock ad new opportun aris remov reason
inclus chang stock met desir return longer rate buy and/or trigger stop loss stock day volatil
bottom quartil stock continu stop loss remaind stop franchis pick intend
repres recommend portfolio stock sector base may note believ pick fall within invest style
growth valu
page
pleas see import disclosur inform page report
